Literature DB >> 7730796

Identification and characterization of the thymidine kinase gene of Yaba virus.

H Amano1, Y Ueda, T Miyamura.   

Abstract

DNA of Yaba virus, a member of the poxviruses, was mapped by cross-hybridization between fragments of various restriction enzymes. The genome was approximately 135 kb in length and possessed two characteristic features of poxviruses: cross-links and inverted terminal repeats at both termini. Hybridization of fragments of Yaba virus DNA to known vaccinia virus DNA fragments indicated that the thymidine kinase (TK) gene mapped within the 0.9 kb XhoI-HincII fragment between 52.5 and 53.5 kb from the left end of the genome. The fragment could rescue the TK+ phenotype in TK- cells preinfected with a TK vaccinia virus mutant. Nucleotide sequencing of the fragment revealed an ORF capable of encoding 181 amino acids. The sequence TAAAAATGAAAAATTA upstream of the ORF was considered to be the promoter and the downstream sequence TTTTTAT to be the early transcription termination signal. These sequences are in good accord with the consensus regulatory sequences for the expression of early genes of other known poxviruses. The amino acid sequence similarity among the poxvirus TK genes suggests that Yaba virus is most closely related to swinepox virus and less similar to fowlpox virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730796     DOI: 10.1099/0022-1317-76-5-1109

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Complete genomic sequence and comparative analysis of the tumorigenic poxvirus Yaba monkey tumor virus.

Authors:  Craig R Brunetti; Hiroko Amano; Yoshiaki Ueda; Jing Qin; Tatsuo Miyamura; Tetsuro Suzuki; Xing Li; John W Barrett; Grant McFadden
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Identification of multiple independent horizontal gene transfers into poxviruses using a comparative genomics approach.

Authors:  Kirsten A Bratke; Aoife McLysaght
Journal:  BMC Evol Biol       Date:  2008-02-27       Impact factor: 3.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.